`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`
`GENENTECH, INC.,
`Plaintiff,
`
`v.
`AMGEN INC.,
`
`
`
`Defendant.
`
`C.A. No. 18-924-CFC
`
`
`
`
`[PROPOSED] ORDER
`
`
`AND NOW, this ____ day of _________________, 2019, having considered Amgen Inc.’s
`
`discovery dispute letter seeking to compel: (1) the continued deposition of named inventor Dr.
`
`Sharon Baughman in view of a critical late-produced email implicating Dr. Brian Leyland-Jones
`
`
`
`as inventor of the Dosing Patents; (2) production of an unredacted form of the late-produced email
`
`referenced above; (3) production of documents in the possession of Roche, Genentech’s parent
`
`entity, relating to Dr. Leyland-Jones and the BO15935 clinical trial that he led; (4) denial of
`
`Genentech’s motion for a protective order to prevent a deposition of Dr. Leyland-Jones; and (5)
`
`production of documents and a 30(b)(6) witness related to licensing the patents-in-suit (the
`
`“Motion to Compel”) and any responses thereto:
`
`IT IS SO ORDERED that the Motion to Compel is GRANTED. Plaintiff’s motion for
`
`protective order is DENIED. IT IS FURTHER ORDERED that:
`
`1.
`
`Genentech shall make available named inventor Dr. Sharon Baughman to continue
`
`her deposition for up to three (3) hours;
`
`2.
`
`Within five (5) days from the date of this Order, Genentech shall produce to counsel
`
`for Amgen Inc. an unredacted form of the Baughman email originally produced on July 23, 2019;
`
`
`
`
`
`
`
`
`
`
`
`Case 1:18-cv-00924-CFC Document 394-1 Filed 10/04/19 Page 2 of 2 PageID #: 29286
`
`
`3.
`
`Within fourteen (14) days from the date of this Order, Genentech shall produce to
`
`counsel for Amgen Inc. non-privileged documents responsive to Amgen Inc.’s Request for
`
`Production Nos. 1, 3, 8, 12, 16, and 53-56 relating to Dr. Leyland-Jones and the BO15935 trial
`
`that are in the possession of Genentech or its parent company, Roche. Any privileged documents
`
`or communications responsive to the Requests shall be included in a supplemental privilege log;
`
`and
`
`4.
`
`Within fourteen (14) days from the date of this Order, Plaintiff shall produce to
`
`counsel for Amgen Inc. documents responsive to Requests for Production Nos. 31 and 65, and any
`
`privileged documents or communications responsive to the Requests shall be included in a
`
`supplemental privilege log. On an agreed date within a reasonable time thereafter, Genentech shall
`
`make available for deposition a Genentech representative pursuant to Fed. R. Civ. P. 30(b)(6) to
`
`
`
`testify concerning Amgen’s Topics 29 and 30.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The Honorable Colm F. Connolly
`
`
`
`
`
`
`
`
`
`2
`
`
`
`